SCHEMBL448807

SCHEMBL448807

[c]1cc[c]c2sccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL452450 0.65 — —
SCHEMBL4805844 0.64 NPC1 (0.30) —
SCHEMBL166404 0.63 — —
SCHEMBL70280 0.57 CYP2A6 (0.31) —
SCHEMBL449535 0.55 — —
SCHEMBL2994954 0.47 — —
Methane SCHEMBL1154428 0.46 — —
SCHEMBL21952429 0.45 CES1 (0.67) —
SCHEMBL387162 0.41 — —
Hydroquinone SCHEMBL612973 0.38 ALOX15 (0.89) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334408-A1 REACTIVE MESOGENS Merck Patent GmbH (DE) 2024-03-13 — — EP disclosed
CN-117280011-A Reactive mesogen 默克专利股份有限公司 2023-12-22 — — CN disclosed
CN-110461824-B Method for producing polymerizable compound and solution 日本瑞翁株式会社 2023-09-05 — — CN disclosed
CN-110382471-B Polymerizable compound, polymerizable liquid crystal mixture, polymer, optical film, optically anisotropic body, polarizing plate, display device, antireflection film, and compound 日本瑞翁株式会社 2023-09-01 — — CN disclosed
CN-110003008-B Mixtures and compounds 日本瑞翁株式会社 2021-11-09 — — CN disclosed
EP-3247701-B1 ANTHELMINTIC COMPOUNDS, COMPOSITIONS AND METHOD OF USING THEREOF BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC (US) 2021-09-22 — — EP disclosed
CN-110431454-B Phase difference plate, multilayer phase difference plate, polarizing plate, image display device, and polymerizable compound 日本瑞翁株式会社 2021-07-16 — — CN disclosed
CN-110088152-B Mixture and method for producing same, polymer, optical film, optically anisotropic body, polarizing plate, display device, and antireflection film 日本瑞翁株式会社 2021-02-12 — — CN disclosed
US-10597364-B2 Anthelmintic compounds, compositions and method of using thereof Boehringer Ingelheim Animal Health USA Inc. (US) 2020-03-24 — — US disclosed
CN-110461824-A Method for producing polymerizable compound and solution ZEON CORP 2019-11-15 — — CN disclosed
EP-2253615-A1 Cyclopropyl amide derivatives AstraZeneca AB (SE) 2010-11-24 — — EP disclosed
EP-2195293-A2 CYCLOPTOPYL AMIDE DERIVATIVES AstraZeneca AB (SE) 2010-06-16 — — EP disclosed
WO-2010062245-A1 SPIROCYCLOBUTYL PIPERIDINE DERIVATIVES ASTRAZENECA AB (SE) 2010-06-03 — — WO disclosed
US-20100130477-A1 Spirocyclobutyl Piperidine Derivatives ASTRAZENECA AB (SE) 2010-05-27 — — US disclosed
US-20090076020-A1 Cyclopropyl Amide Derivatives 978 ASTRAZENECA AB (SE) 2009-03-19 — — US disclosed
WO-2009024823-A2 OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS ASTRAZENECA AB (SE) 2009-02-26 — — WO disclosed
US-20050085447-A1 Pyrido[3,4-d]pyrimidine derivatives as matrix metalloproteinase-13 inhibitors WARNER-LAMBERT COMPANY LLC 2005-04-21 — — US disclosed
WO-2005016926-A1 PYRIDO [3,4-D] PYRIMIDINE DERIVATIVES AS MATRIX METALLOPROTEINASE-13 INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2005-02-24 — — WO disclosed
US-6673804-B1 PREVENTING OR TREATING ARTHRITIS (PARTICULARLY OSTEOARTHRITIS) OR INHIBITING METASTASIS, INVASION OR GROWTH OF CANCER (PARTICULARLY BREAST CANCER) SANKYO COMPANY, LIMITED (JP) 2004-01-06 — — US disclosed
EP-1069110-A1 SULFONAMIDE DERIVATIVES Sankyo Company Limited (JP) 2001-01-17 — — EP disclosed
Send feedback